<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04309383</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00042422</org_study_id>
    <nct_id>NCT04309383</nct_id>
  </id_info>
  <brief_title>ShuntCheck in Pseudotumor Cerebri</brief_title>
  <official_title>Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Pseudotumor Cerebri</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NeuroDx Development</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of South Florida</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine if the ShuntCheck test can correctly identify flow
      or no flow in a ventriculoperitoneal shunt in patients with pseudotumor cerebri.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 29, 2019</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Specificity of ShuntCheck test</measure>
    <time_frame>15 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative Predictive Value of ShuntCheck test</measure>
    <time_frame>15 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Specificity of performing ShuntCheck test twice</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative Predictive Value of performing ShuntCheck test twice</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pseudotumor Cerebri</condition>
  <arm_group>
    <arm_group_label>ShuntCheck</arm_group_label>
    <description>Participants will be administered the ShuntCheck diagnostic test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ShuntCheck</intervention_name>
    <description>The intervention is an FDA-cleared device utilizing a transcutaneous thermal convection to analyze shunt flow.</description>
    <arm_group_label>ShuntCheck</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of asymptomatic PTC research subjects who have a VP shunt
        with a single ventricular catheter implanted for PTC and are visiting for routine care.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old or older Adult men or women who possess a VP shunt placed for PTC;

          -  Capable of providing valid signed informed consent, or has a legal guardian, health
             care agent, or surrogate decision maker (according to local statutes, and collectively
             referred to as &quot;surrogates&quot; in this protocol) capable of providing valid, signed
             informed consent;

          -  Subjects will be asymptomatic visiting for routine care at 2-4 weeks post op

        Exclusion Criteria:

          -  Presence of multiple shunts, or presence of more than one distal shunt catheter
             (regardless of function) crossing the clavicle ipsilateral to the shunt with suspected
             obstruction;

          -  ShuntCheck test would interfere with standard patient care, or emergency shunt surgery
             that cannot be delayed is indicated;

          -  Presence of an interfering open wound or edema over any portion of the VP shunt.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Naomi Abel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of South Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Naomi Abel, MD</last_name>
    <phone>813 259-0904</phone>
    <email>nabel@usf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Konrad Bach, MD</last_name>
    <phone>813 259-8898</phone>
    <email>kbach@usf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of South Florida Department of Neurological Surgery and Brain Repair</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naomi Abel, MD</last_name>
      <phone>813-259-0904</phone>
      <email>nabel@usf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Konrad Bach, MD</last_name>
      <phone>813 259-8898</phone>
      <email>kbach@usf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Naomi Abel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 12, 2020</study_first_submitted>
  <study_first_submitted_qc>March 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2020</study_first_posted>
  <last_update_submitted>March 12, 2020</last_update_submitted>
  <last_update_submitted_qc>March 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of South Florida</investigator_affiliation>
    <investigator_full_name>Naomi Abel</investigator_full_name>
    <investigator_title>Assistant Professor, College of Medicine Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>Pseudotumor Cerebri, Ventriculoperitoneal Shunt</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pseudotumor Cerebri</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>At present there is no plan to share any individual participant data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

